RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
G
APOB
apolipoprotein B
ISO
protein:increased expression:serum
RGD
PMID:18076041
RGD:2325763
NCBI chr2A:20,986,464...21,029,004
Ensembl chr2A:21,100,356...21,145,129
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
DNA:polymorphism:exon:rs2606345 (human)
RGD
PMID:19168589
RGD:2317210
NCBI chr15:53,664,968...53,672,277
Ensembl chr15:73,284,566...73,290,636
G
PPARD
peroxisome proliferator activated receptor delta
ISO
RGD
PMID:18497548
RGD:2324871
NCBI chr 6:34,903,798...34,987,208
Ensembl chr 6:36,003,988...36,081,132
G
DDR2
discoidin domain receptor tyrosine kinase 2
disease_progression
ISO
RGD
PMID:29043607
RGD:150429712
NCBI chr 1:138,048,730...138,200,426
Ensembl chr 1:141,932,158...141,990,766
G
IFITM1
interferon induced transmembrane protein 1
disease_progression
ISO
RGD
PMID:29043607
RGD:150429712
NCBI chr11:309,930...311,177
Ensembl chr11:353,236...354,986
G
SLC7A5
solute carrier family 7 member 5
disease_progression
ISO
RGD
PMID:24131658
RGD:151361287
NCBI chr16:68,512,407...68,552,763
G
APOB
apolipoprotein B
susceptibility
ISO
DNA:polymorphisms:intron, exon:IVS6+360C>T, 56C>T (human)
RGD
PMID:18296645
RGD:2317550
NCBI chr2A:20,986,464...21,029,004
Ensembl chr2A:21,100,356...21,145,129
G
APOE
apolipoprotein E
susceptibility
ISO
DNA:SNP:intron:rs440446 (human)
RGD
PMID:18296645
RGD:2317550
NCBI chr19:41,853,669...41,857,252
Ensembl chr19:50,459,906...50,463,490
G
ATM
ATM serine/threonine kinase
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:9887333 PMID:17124347 PMID:20077034 PMID:25741868 PMID:26635394 PMID:28492532 More...
NCBI chr11:103,109,979...103,256,405
Ensembl chr11:106,584,228...106,727,041
G
MLH1
mutL homolog 1
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:15340264 PMID:17510385 PMID:18307539 PMID:19419416 PMID:22136435 PMID:22703879 PMID:24033266 PMID:24728327 PMID:25741868 PMID:28492532 More...
NCBI chr 3:36,899,828...36,957,076
Ensembl chr 3:37,189,439...37,245,801
G
MSH2
mutS homolog 2
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:25741868 PMID:33357406
NCBI chr2A:47,524,468...47,602,376
Ensembl chr2A:48,447,207...48,554,461
G
PALB2
partner and localizer of BRCA2
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:25741868 PMID:26467025 PMID:28492532 PMID:30287823
NCBI chr16:14,470,367...14,507,841
Ensembl chr16:23,855,535...23,892,117
G
PKD1
polycystin 1, transient receptor potential channel interacting
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:12007219 PMID:16430766 PMID:17574468 PMID:25741868 PMID:26467025 PMID:27782177 More...
NCBI chr16:604,366...605,560
G
POLD1
DNA polymerase delta 1, catalytic subunit
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:25741868 PMID:26467025 PMID:28492532
NCBI chr19:47,347,919...47,381,772
Ensembl chr19:56,251,356...56,297,611
G
STK11
serine/threonine kinase 11
ISO
ClinVar Annotator: match by term: Bile duct cancer
ClinVar
PMID:25741868 PMID:28492532
Ensembl chr19:1,188,537...1,210,677
G
TJP1
tight junction protein 1
ISO
protein:decreased expression:bile duct
RGD
PMID:19184677
RGD:2325030
NCBI chr15:981,198...1,249,292
Ensembl chr15:26,344,878...26,598,878
G
MSLN
mesothelin
ISO
protein:increased expression:bile duct
RGD
PMID:17276942
RGD:2326059
Ensembl chr16:777,146...783,449
G
SLC7A5
solute carrier family 7 member 5
disease_progression
ISO
RGD
PMID:24890221
RGD:151361210
NCBI chr16:68,512,407...68,552,763
G
ABCC2
ATP binding cassette subfamily C member 2
susceptibility
ISO
DNA:polymorphism:exon:c.3972C>T (human)
RGD
PMID:19451719
RGD:2317508
NCBI chr10:96,385,534...96,458,571
Ensembl chr10:99,889,160...99,947,270
G
ADRB2
adrenoceptor beta 2
ISO
protein:decreased expression:liver
RGD
PMID:16292515
RGD:2325640
NCBI chr 5:144,259,756...144,398,421
Ensembl chr 5:150,267,554...150,315,892
G
ALB
albumin
disease_progression
ISO
RGD
PMID:10776430 PMID:17545000 PMID:20431764
RGD:2325679 RGD:2325680 RGD:2325682
NCBI chr 4:50,773,244...50,790,474
Ensembl chr 4:56,605,322...56,622,418
G
ALOX5
arachidonate 5-lipoxygenase
ISO
protein:increased expression:bile duct
RGD
PMID:18507031
RGD:2317521
NCBI chr10:42,461,398...42,531,576
Ensembl chr10:45,639,946...45,710,016
G
ANXA2
annexin A2
disease_progression
ISO
RGD
PMID:20493868
RGD:2325728
NCBI chr15:39,322,303...39,371,565
Ensembl chr15:57,625,425...57,674,250
G
APC
APC regulator of WNT signaling pathway
ISO
DNA:hypermethylation:promoter DNA:loss of heterozygosity
RGD
PMID:10212000 PMID:15467712
RGD:2317198 RGD:2317205
NCBI chr 5:108,070,697...108,208,273
Ensembl chr 5:113,904,352...114,009,709
G
APOA1
apolipoprotein A1
ISO
protein:decreased expression:serum
RGD
PMID:19486127
RGD:2325756
NCBI chr11:111,673,539...111,675,428
Ensembl chr11:115,606,136...115,608,122
G
ARID1A
AT-rich interaction domain 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24185509
NCBI chr 1:25,960,868...26,047,057
Ensembl chr 1:27,018,616...27,103,239
G
ASPH
aspartate beta-hydroxylase
ISO
RGD
PMID:21898484
RGD:6902945
NCBI chr 8:57,921,580...58,134,778
Ensembl chr 8:59,629,707...59,843,658
G
ATG101
autophagy related 101
disease_progression
ISO
RGD
PMID:35592424
RGD:153350091
NCBI chr12:36,685,897...36,693,613
Ensembl chr12:37,462,533...37,470,062
G
BAP1
BRCA1 associated deubiquitinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24185509 PMID:25231345
NCBI chr 3:52,344,067...52,352,187
Ensembl chr 3:53,573,785...53,581,943
G
BIRC6
baculoviral IAP repeat containing 6
ameliorates
ISO
mRNA:increased expression:bile duct (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr2A:32,373,479...32,633,088
Ensembl chr2A:33,084,929...33,343,245
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
ISO
DNA:missense mutation:cds:p.V600E (human)
RGD
PMID:12692057
RGD:11073239
NCBI chr 7:132,651,908...132,855,422
Ensembl chr 7:145,138,510...145,327,115
G
CDKN2A
cyclin dependent kinase inhibitor 2A
onset
ISO
protein:decreased expression:liver
RGD
PMID:15619210
RGD:2317417
NCBI chr 9:21,803,862...21,831,322
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:18550579
NCBI chr 4:50,452,857...50,456,015
Ensembl chr 4:56,286,708...56,288,083
G
CXCR1
C-X-C motif chemokine receptor 1
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:18550579
NCBI chr2B:105,429,576...105,433,243
Ensembl chr2B:224,028,838...224,029,890
G
CYP24A1
cytochrome P450 family 24 subfamily A member 1
ISO
protein:increased expression:intrahepatic bile, extrahepatic bile duct (human)
RGD
PMID:23375797
RGD:151361187
NCBI chr20:50,500,103...50,520,487
Ensembl chr20:51,721,685...51,742,716
G
EGF
epidermal growth factor
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:18550579 PMID:25741868 PMID:28492532
NCBI chr 4:102,410,724...102,509,691
Ensembl chr 4:112,977,565...113,076,460
G
EGFR
epidermal growth factor receptor
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:18550579 PMID:24728327 PMID:25741868 PMID:28492532
NCBI chr 7:55,614,042...55,807,285
Ensembl chr 7:56,046,296...56,111,615
G
EPO
erythropoietin
ISO
mRNA, protein:increased expression:liver
RGD
PMID:23052842
RGD:10400912
NCBI chr 7:92,747,671...92,750,886
Ensembl chr 7:106,148,062...106,150,974
G
EPOR
erythropoietin receptor
ISO
mRNA, protein:increased expression:liver
RGD
PMID:23052842
RGD:10400912
NCBI chr19:10,925,148...10,931,955
Ensembl chr19:11,635,248...11,642,383
G
ERBB2
erb-b2 receptor tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16818635
NCBI chr17:17,560,337...17,600,808
Ensembl chr17:17,777,434...17,805,862
G
EZH2
enhancer of zeste 2 polycomb repressive complex 2 subunit
no_association disease_progression
ISO
DNA:SNPs: :g.148525904C>G, (rs2302427), g.148519011C>T (rs6464926), g.148517456T>G (rs17171119) (human) DNA:SNP: :g.148505302C>T (rs887569) (human)
RGD
PMID:24179546
RGD:126779604
NCBI chr 7:140,536,962...140,613,104
Ensembl chr 7:153,017,590...153,059,726
G
FASLG
Fas ligand
ISO
RGD
PMID:11029528
RGD:2317746
NCBI chr 1:148,159,826...148,167,785
Ensembl chr 1:151,868,430...151,876,281
G
FGF2
fibroblast growth factor 2
ISO
protein:increased expression:bile
RGD
PMID:11478488
RGD:2317765
NCBI chr 4:115,005,136...115,076,369
Ensembl chr 4:126,149,813...126,214,942
G
FGFR2
fibroblast growth factor receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26258846
NCBI chr10:118,055,854...118,175,440
Ensembl chr10:121,469,735...121,588,815
G
FSCN1
fascin actin-bundling protein 1
disease_progression
ISO
protein:increased expression:bile ducts
RGD
PMID:19721413
RGD:2317780
NCBI chr 7:5,848,902...5,862,756
G
GNAS
GNAS complex locus
disease_progression
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:393T>C (human)
CTD RGD
PMID:17356712 PMID:22561520
RGD:1601377
NCBI chr20:55,190,607...55,262,245
G
GSTM1
glutathione S-transferase mu 1
ISO
RGD
PMID:24049014
RGD:14700980
Ensembl chr 1:127,979,238...128,010,411
G
GSTP1
glutathione S-transferase pi 1
treatment
ISO
human cell line in a mouse model DNA:hypermethylation:promoter
RGD
PMID:12805482 PMID:15467712
RGD:14401711 RGD:2317198
NCBI chr11:62,942,756...62,945,701
Ensembl chr11:66,253,421...66,256,472
G
HDAC6
histone deacetylase 6
ISO
protein:increased expression:liver:
RGD
PMID:23370327
RGD:9681560
NCBI chr X:41,099,539...41,122,650
Ensembl chr X:48,960,430...48,982,642
G
HGF
hepatocyte growth factor
ISO
mRNA, protein:increased expression: : protein:increased expression:serum
RGD
PMID:10827151 PMID:16974053
RGD:2317909 RGD:2317925
NCBI chr 7:73,667,618...73,738,960
Ensembl chr 7:87,327,798...87,397,811
G
HIF1A
hypoxia inducible factor 1 subunit alpha
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:12919954 PMID:18550579 PMID:22647679 PMID:24120591 PMID:25741868
NCBI chr14:42,295,691...42,348,478
Ensembl chr14:60,552,374...60,604,885
G
HNF1B
HNF1 homeobox B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:39887605
NCBI chr17:19,333,485...19,392,147
Ensembl chr17:19,633,424...19,691,863
G
IDH1
isocitrate dehydrogenase (NADP(+)) 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24185509
NCBI chr2B:95,475,320...95,494,286
Ensembl chr2B:213,599,036...213,617,175
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24185509
NCBI chr15:68,771,050...68,790,523
Ensembl chr15:87,972,889...87,991,276
G
IL10
interleukin 10
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 PMID:28492532 More...
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL19
interleukin 19
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 PMID:28492532 More...
NCBI chr 1:182,372,339...182,446,147
Ensembl chr 1:186,651,640...186,724,748
G
IL1B
interleukin 1 beta
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:18550579
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
IL1R2
interleukin 1 receptor type 2
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
Ensembl chr2A:103,042,328...103,078,190
G
IL4R
interleukin 4 receptor
ISO
mRNA:increased expression:bile duct
RGD
PMID:18798553
RGD:2317263
Ensembl chr16:27,642,702...27,737,445
G
IL6
interleukin 6
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:9769329 PMID:10720087 PMID:11001912 PMID:11889177 PMID:12519862 PMID:12560873 PMID:12719374 PMID:15070960 PMID:15331795 PMID:15472205 PMID:16150725 PMID:16278864 PMID:17623760 PMID:18550579 More...
NCBI chr 7:23,415,922...23,420,767
G
INS
insulin
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr11:2,200,785...2,202,579
Ensembl chr11:2,218,117...2,231,666
G
KCND2
potassium voltage-gated channel subfamily D member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34418280
NCBI chr 7:112,277,018...112,751,896
Ensembl chr 7:124,966,816...125,437,430
G
KIT
KIT proto-oncogene, receptor tyrosine kinase
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 4:69,199,543...69,282,323
Ensembl chr 4:75,761,946...75,844,473
G
KMT2C
lysine methyltransferase 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561520
NCBI chr 7:143,714,716...144,016,188
Ensembl chr 7:155,862,610...156,081,043
G
KRAS
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8968066 PMID:22561520
NCBI chr12:61,062,689...61,108,524
Ensembl chr12:63,679,293...63,724,335
G
KRT7
keratin 7
ISO
RGD
PMID:18393293
RGD:2317308
NCBI chr12:36,514,021...36,529,721
Ensembl chr12:37,291,244...37,307,341
G
LOC100986481
cytochrome c
ISO
RGD
PMID:19788692
RGD:2317615
NCBI chr 7:25,784,900...25,791,598
Ensembl chr 7:25,396,013...25,398,549
G
LOC100987733
paternally-expressed gene 3 protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561520
NCBI chr19:53,830,193...53,860,760
Ensembl chr19:62,588,511...62,654,661
G
LOC100991392
serine protease 2
ISO
protein:increased expression:serum
RGD
PMID:8621252
RGD:2324908
NCBI chr 7:134,761,471...134,765,816
Ensembl chr 7:147,223,606...147,257,587
G
MDM2
MDM2 proto-oncogene
disease_progression
ISO
protein:increased expression:intrahepatic bile duct (human)
RGD
PMID:15619210
RGD:2317417
NCBI chr12:66,322,340...66,357,010
Ensembl chr12:69,102,084...69,133,278
G
MET
MET proto-oncogene, receptor tyrosine kinase
disease_progression
ISO
protein:increased expression:liver, biliary epithelium (rat) protein:increased phosphorylation:liver, carcinoma (human)
RGD
PMID:14656942 PMID:16818635
RGD:2317578 RGD:2317601
NCBI chr 7:108,646,278...108,772,238
Ensembl chr 7:121,365,438...121,468,159
G
MFSD4A
major facilitator superfamily domain containing 4A
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 1:181,177,517...181,211,432
Ensembl chr 1:185,474,032...185,497,408
G
MGMT
O-6-methylguanine-DNA methyltransferase
ISO
DNA:hypermethylation:promoter (human)
RGD
PMID:17550320
RGD:2317632
NCBI chr10:126,059,701...126,365,850
Ensembl chr10:130,305,485...130,609,422
G
MKI67
marker of proliferation Ki-67
disease_progression
ISO
RGD
PMID:12903495
RGD:2317705
NCBI chr10:124,684,336...124,714,143
Ensembl chr10:128,936,037...128,962,555
G
MMP2
matrix metallopeptidase 2
disease_progression
ISO
protein:increased expression:bile duct
RGD
PMID:15213623 PMID:19629755
RGD:2324667 RGD:2325769
NCBI chr16:35,711,866...35,738,881
Ensembl chr16:54,812,694...54,844,279
G
MMP9
matrix metallopeptidase 9
ISO
protein:increased expression:bile duct mRNA:increased expression:bile duct
RGD
PMID:15213623 PMID:16463672
RGD:2324667 RGD:2325856
NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129
G
MSLN
mesothelin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14576474
Ensembl chr16:777,146...783,449
G
MTHFR
methylenetetrahydrofolate reductase
susceptibility
ISO
DNA:polymorphism (human)
RGD
PMID:17201138
RGD:2317119
NCBI chr 1:10,548,196...10,568,174
Ensembl chr 1:11,766,334...11,785,419
G
MUC1
mucin 1, cell surface associated
disease_progression
ISO
mRNA:increased expression:bile duct protein:increased secretion:bile protein:increased expression:serum protein:increased expression:bile duct:
RGD
PMID:15213623 PMID:18081149 PMID:19055478 PMID:19260467 PMID:19639217
RGD:2317986 RGD:2324622 RGD:2324638 RGD:2324664 RGD:2324667
NCBI chr 1:130,533,508...130,537,866
Ensembl chr 1:134,141,969...134,145,850
G
MUC16
mucin 16, cell surface associated
ISO
associated with Opisthorchiasis;protein:increased expression:serum
RGD
PMID:1653472
RGD:2325142
NCBI chr19:8,416,393...8,568,418
G
MUC2
mucin 2, oligomeric mucus/gel-forming
ISO
mRNA:decreased expression:bile duct
RGD
PMID:11680592
RGD:2324948
NCBI chr11:1,106,716...1,144,489
Ensembl chr11:1,143,625...1,169,741
G
MUC3A
mucin 3A, cell surface associated
ISO
mRNA:decreased expression:bile duct
RGD
PMID:11680592
RGD:2324948
NCBI chr 7:92,974,006...92,993,990
G
MUC4
mucin 4, cell surface associated
disease_progression
ISO
protein:increased expression:bile duct
RGD
PMID:14752841 PMID:19082442
RGD:2303602 RGD:2324944
NCBI chr 3:193,050,895...193,114,931
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
disease_progression
ISO
mRNA:increased expression:bile duct protein:increased expression:serum
RGD
PMID:11680592 PMID:14508831
RGD:2324948 RGD:2324990
NCBI chr11:1,191,223...1,234,373
G
MUC5B
mucin 5B, oligomeric mucus/gel-forming
ISO
mRNA:decreased expression:bile duct
RGD
PMID:11680592
RGD:2324948
G
MUC6
mucin 6, oligomeric mucus/gel-forming
ISO
protein:increased expression: :
RGD
PMID:10209489
RGD:2325167
NCBI chr11:1,035,447...1,071,791
Ensembl chr11:1,077,867...1,106,927
G
NAT2
N-acetyltransferase 2
ISO
DNA:polymorphisms (human)
RGD
PMID:15901993
RGD:2317172
NCBI chr 8:17,606,445...17,623,397
Ensembl chr 8:14,575,455...14,576,327
G
NCAM1
neural cell adhesion molecule 1
ISO
associated with hepatitis
RGD
PMID:12031086
RGD:2326079
NCBI chr11:107,845,507...108,160,441
Ensembl chr11:111,925,677...112,000,401
G
NOS2
nitric oxide synthase 2
ISO
protein:increased expression:bile duct CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16094703 PMID:16818635
RGD:2325280
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
G
NOTCH1
notch receptor 1
ISO
protein:increased expression:cholangiocyte
RGD
PMID:15887117
RGD:2325330
NCBI chr 9:107,568,670...107,621,032
Ensembl chr 9:136,544,639...136,598,740
G
NR1H4
nuclear receptor subfamily 1 group H member 4
disease_progression
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:24255171
RGD:15090822
NCBI chr12:98,052,778...98,144,085
Ensembl chr12:101,457,885...101,548,058
G
OGG1
8-oxoguanine DNA glycosylase
disease_progression
ISO
DNA:loss of heterozygosity (human)
RGD
PMID:11260864 PMID:11866974
RGD:2317134 RGD:2317136
NCBI chr 3:9,702,311...9,742,283
Ensembl chr 3:9,940,955...9,947,335
G
OSBP2
oxysterol binding protein 2
ISO
mRNA:increased expression:blood
RGD
PMID:21763455
RGD:41404644
NCBI chr22:11,719,017...11,933,841
Ensembl chr22:29,520,479...29,733,061
G
OSBPL7
oxysterol binding protein like 7
ISO
mRNA:increased expression:blood
RGD
PMID:21763455
RGD:41404644
NCBI chr17:9,715,464...9,729,950
Ensembl chr17:9,897,768...9,912,065
G
PANX2
pannexin 2
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr22:30,398,717...30,408,358
Ensembl chr22:49,404,624...49,408,045
G
PAWR
pro-apoptotic WT1 regulator
ISO
mRNA,protein:decreased expression:cholangiocyte:
RGD
PMID:20724592
RGD:9835357
NCBI chr12:77,114,282...77,224,116
Ensembl chr12:79,969,517...80,070,796
G
PBRM1
polybromo 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24185509
NCBI chr 3:52,487,083...52,626,418
Ensembl chr 3:53,718,051...53,850,146
G
PES1
pescadillo ribosomal biogenesis factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34845814
NCBI chr22:11,604,897...11,620,187
Ensembl chr22:29,406,095...29,420,868
G
PIR
pirin
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr X:8,011,382...8,121,994
Ensembl chr X:15,294,099...15,404,004
G
PPIA
peptidylprolyl isomerase A
ameliorates
ISO
human cell line and construct in a mouse model
RGD
PMID:21871105
RGD:150429623
NCBI chr 7:45,510,450...45,515,448
Ensembl chr 7:45,578,765...45,605,545
G
PPP3CA
protein phosphatase 3 catalytic subunit alpha
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 4:93,447,095...93,770,339
Ensembl chr 4:104,113,520...104,435,394
G
PREX2
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2
sexual_dimorphism
ISO
DNA:substitutions, insertion/deletions: (human)
RGD
PMID:28000796
RGD:151665188
NCBI chr 8:64,489,817...64,769,602
Ensembl chr 8:66,215,974...66,430,138
G
PRKACA
protein kinase cAMP-activated catalytic subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26258846
NCBI chr19:13,657,344...13,683,864
Ensembl chr19:14,385,191...14,406,205
G
PRKACB
protein kinase cAMP-activated catalytic subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26258846
NCBI chr 1:116,625,640...116,786,396
Ensembl chr 1:85,487,681...85,644,253
G
PRRG4
proline rich and Gla domain 4
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr11:32,790,274...32,816,067
Ensembl chr11:32,678,175...32,702,862
G
PRSS56
serine protease 56
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr2B:119,751,950...119,757,308
Ensembl chr2B:238,670,931...238,675,839
G
PTEN
phosphatase and tensin homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23376645 PMID:27022031
RGD:12802341
NCBI chr10:84,587,841...84,689,043
Ensembl chr10:88,093,539...88,194,605
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
NCBI chr 1:162,205,534...162,214,130
Ensembl chr 1:166,355,845...166,364,519
G
RASSF8
Ras association domain family member 8
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr12:60,246,885...60,361,888
Ensembl chr12:62,867,015...62,880,512
G
RNF39
ring finger protein 39
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 6:29,848,055...29,853,659
G
RNF43
ring finger protein 43
exacerbates
ISO
CTD Direct Evidence: marker/mechanism associated with opisthorchiasis;DNA:SNPs:multiple: (human)
CTD RGD
PMID:22561520
RGD:151361227
NCBI chr17:52,420,516...52,492,813
Ensembl chr17:57,276,761...57,347,748
G
ROBO2
roundabout guidance receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561520
NCBI chr 3:76,013,780...77,764,156
Ensembl chr 3:79,030,223...79,632,309
G
RUNX3
RUNX family transcription factor 3
ISO
protein:decreased expression:bile duct
RGD
PMID:19827872
RGD:2324955
NCBI chr 1:24,097,321...24,164,065
Ensembl chr 1:25,073,134...25,137,335
G
SLC4A4
solute carrier family 4 member 4
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 4:52,659,221...52,994,053
Ensembl chr 4:59,002,200...59,385,608
G
SLC5A5
solute carrier family 5 member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17408651
NCBI chr19:17,352,635...17,377,130
Ensembl chr19:18,327,410...18,344,480
G
SLC7A5
solute carrier family 7 member 5
disease_progression treatment
ISO
RGD
PMID:24131658 PMID:25475870 PMID:28347255
RGD:151361214 RGD:151361287 RGD:151361294
NCBI chr16:68,512,407...68,552,763
G
SMAD4
SMAD family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561520
NCBI chr18:44,402,112...44,456,779
Ensembl chr18:47,764,568...47,797,359
G
SOCS3
suppressor of cytokine signaling 3
severity
ISO
protein:decreased expression:bile duct (human)
RGD
PMID:26485275
RGD:11250478
NCBI chr17:72,433,206...72,436,500
Ensembl chr17:77,983,389...77,984,066
G
SOX17
SRY-box transcription factor 17
severity
ISO
RGD
PMID:20816680
RGD:4889598
NCBI chr 8:50,883,088...50,885,542
Ensembl chr 8:48,257,287...48,259,808
G
SOX2
SRY-box transcription factor 2
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 3:178,744,881...178,747,392
Ensembl chr 3:186,922,705...186,923,662
G
TGFB1
transforming growth factor beta 1
disease_progression
ISO
protein:increased expression:pancreas
RGD
PMID:12632524 PMID:16083599
RGD:1299231 RGD:2325020
NCBI chr19:38,324,009...38,347,003
Ensembl chr19:46,831,659...46,852,973
G
TGFBR2
transforming growth factor beta receptor 2
ISO
mRNA:increased expression:bile duct
RGD
PMID:12632524
RGD:1299231
NCBI chr 3:30,536,187...30,623,653
Ensembl chr 3:30,854,460...30,938,856
G
THBS1
thrombospondin 1
disease_progression
ISO
DNA:hypermethylation (human)
RGD
PMID:11927969 PMID:12213730 PMID:16465407
RGD:2325024 RGD:2325026 RGD:2325027
NCBI chr15:18,521,802...18,538,172
Ensembl chr15:36,776,756...36,793,170
G
TNC
tenascin C
severity
ISO
RGD
PMID:20816680
RGD:4889598
NCBI chr 9:86,125,672...86,222,804
Ensembl chr 9:114,486,778...114,584,299
G
TNFAIP3
TNF alpha induced protein 3
severity
ISO
protein:increased expression:bile duct (human)
RGD
PMID:26485275
RGD:11250478
NCBI chr 6:135,617,465...135,634,085
Ensembl chr 6:139,705,255...139,720,819
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16818635 PMID:22561520
NCBI chr17:7,699,449...7,717,812
Ensembl chr17:7,684,922...7,706,120
G
TTR
transthyretin
ISO
protein:decreased expression:blood serum (human)
RGD
PMID:18275060
RGD:151660506
NCBI chr18:24,809,707...24,816,713
Ensembl chr18:28,407,893...28,414,960
G
VEGFA
vascular endothelial growth factor A
ISO
ClinVar Annotator: match by term: Cholangiocarcinoma
ClinVar
PMID:18550579
NCBI chr 6:43,361,053...43,377,366
Ensembl chr 6:44,650,365...44,666,353
G
WDHD1
WD repeat and HMG-box DNA binding protein 1
ameliorates
ISO
RGD
PMID:30314946
RGD:156420141
NCBI chr14:35,528,981...35,614,145
Ensembl chr14:53,807,684...53,889,703
G
WNT9A
Wnt family member 9A
disease_progression
ISO
mRNA:altered expression:liver (human)
RGD
PMID:31687280
RGD:152998978
NCBI chr 1:203,320,990...203,350,599
Ensembl chr 1:208,300,609...208,327,191
G
BAP1
BRCA1 associated deubiquitinase 1
disease_progression
ISO
RGD
PMID:25536104
RGD:150340631
NCBI chr 3:52,344,067...52,352,187
Ensembl chr 3:53,573,785...53,581,943
G
PBRM1
polybromo 1
disease_progression
ISO
RGD
PMID:25536104
RGD:150340631
NCBI chr 3:52,487,083...52,626,418
Ensembl chr 3:53,718,051...53,850,146
G
RAC1
Rac family small GTPase 1
ISO
protein:increased expression:mucosa (human)
RGD
PMID:21537609
RGD:153350126
NCBI chr 7:7,039,379...7,068,866
G
SLC7A5
solute carrier family 7 member 5
disease_progression
ISO
RGD
PMID:24890221
RGD:151361210
NCBI chr16:68,512,407...68,552,763
G
PKD1
polycystin 1, transient receptor potential channel interacting
ISO
ClinVar Annotator: match by term: Extrahepatic bile duct cancer
ClinVar
PMID:25741868
NCBI chr16:604,366...605,560
G
POLD1
DNA polymerase delta 1, catalytic subunit
ISO
ClinVar Annotator: match by term: Extrahepatic bile duct cancer
ClinVar
PMID:25741868 PMID:26467025 PMID:28492532
NCBI chr19:47,347,919...47,381,772
Ensembl chr19:56,251,356...56,297,611
G
XPO1
exportin 1
disease_progression
ISO
protein:increased expression:extrahepatic bile duct (human)
RGD
PMID:27279267
RGD:151665800
NCBI chr2A:61,562,372...61,622,841
Ensembl chr2A:62,698,935...62,757,793
G
ACE
angiotensin I converting enzyme
ISO
DNA:polymorphism: :rs4646994 (human)
RGD
PMID:20438364
RGD:2325207
NCBI chr17:57,556,294...57,577,294
Ensembl chr17:62,702,341...62,733,853
G
CDK1
cyclin dependent kinase 1
ISO
protein:increased expression:gallbladder
RGD
PMID:15017593
RGD:2722465
NCBI chr10:57,314,692...57,331,261
Ensembl chr10:59,647,993...59,664,434
G
DDR2
discoidin domain receptor tyrosine kinase 2
disease_progression
ISO
RGD
PMID:29043607
RGD:150429712
NCBI chr 1:138,048,730...138,200,426
Ensembl chr 1:141,932,158...141,990,766
G
IFITM1
interferon induced transmembrane protein 1
disease_progression
ISO
RGD
PMID:29043607
RGD:150429712
NCBI chr11:309,930...311,177
Ensembl chr11:353,236...354,986
G
APC
APC regulator of WNT signaling pathway
disease_progression
ISO
DNA:SNP::rs11954856(human)
RGD
PMID:26715268
RGD:151356500
NCBI chr 5:108,070,697...108,208,273
Ensembl chr 5:113,904,352...114,009,709
G
APOB
apolipoprotein B
susceptibility
ISO
DNA:SNP: :rs693 (human)
RGD
PMID:17696941 PMID:20082485
RGD:2325761 RGD:2325764
NCBI chr2A:20,986,464...21,029,004
Ensembl chr2A:21,100,356...21,145,129
G
APOE
apolipoprotein E
susceptibility
ISO
DNA:SNP:intron:rs440446 (human)
RGD
PMID:18296645
RGD:2317550
NCBI chr19:41,853,669...41,857,252
Ensembl chr19:50,459,906...50,463,490
G
AXIN2
axin 2
disease_progression
ISO
DNA:SNP::s4791171(human)
RGD
PMID:26715268
RGD:151356500
NCBI chr17:59,476,336...59,509,358
Ensembl chr17:64,688,416...64,720,086
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
NCBI chr 7:132,651,908...132,855,422
Ensembl chr 7:145,138,510...145,327,115
G
BUB1B
BUB1 mitotic checkpoint serine/threonine kinase B
ISO
mRNA:increased expression:gallbladder
RGD
PMID:18497548
RGD:2324871
NCBI chr15:19,095,383...19,155,557
Ensembl chr15:37,350,826...37,410,648
G
CALR
calreticulin
exacerbates
ISO
mRNA, protein:increased expression:gall bladder (human)
RGD
PMID:33591948
RGD:150521682
NCBI chr19:12,501,013...12,506,909
Ensembl chr19:13,242,900...13,249,416
G
CCR5
C-C motif chemokine receptor 5
onset
ISO
DNA:frameshift mutation:cds:p.S185_T195del rs333 (human)
RGD
PMID:18405329
RGD:2317570
NCBI chr 3:46,273,096...46,278,471
Ensembl chr 3:47,380,321...47,381,379
G
CTNNB1
catenin beta 1
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:10435629 PMID:26822237
NCBI chr 3:41,104,940...41,145,934
Ensembl chr 3:41,373,726...41,414,030
G
CYP17A1
cytochrome P450 family 17 subfamily A member 1
susceptibility
ISO
DNA:transition:5' utr:-34T>C rs743572 (human)
RGD
PMID:16381022
RGD:2317619
NCBI chr10:99,431,762...99,439,619
Ensembl chr10:102,896,376...102,901,514
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
DNA:polymorphism: :p.I462V (human) DNA:transition: :6235T>C (human)
RGD
PMID:18287863 PMID:18990008
RGD:2317211 RGD:2317212
NCBI chr15:53,664,968...53,672,277
Ensembl chr15:73,284,566...73,290,636
G
DPYD
dihydropyrimidine dehydrogenase
disease_progression
ISO
RGD
PMID:16619549
RGD:2317631
NCBI chr 1:99,736,145...100,576,663
Ensembl chr 1:98,457,934...99,300,100
G
EGF
epidermal growth factor
susceptibility
ISO
DNA:SNP: :+61A>G (rs4444903)(human)
RGD
PMID:8093356 PMID:18571008
RGD:2317641 RGD:2317646
NCBI chr 4:102,410,724...102,509,691
Ensembl chr 4:112,977,565...113,076,460
G
GLI1
GLI family zinc finger 1
disease_progression
ISO
DNA:SNP::rs2228226(human)
RGD
PMID:26715268
RGD:151356500
NCBI chr12:31,453,759...31,466,194
Ensembl chr12:31,710,057...31,722,473
G
GSTM1
glutathione S-transferase mu 1
ISO
RGD
PMID:26925680
RGD:14700928
Ensembl chr 1:127,979,238...128,010,411
G
JUNB
JunB proto-oncogene, AP-1 transcription factor subunit
exacerbates
ISO
protein:increased expression:gall bladder (human)
RGD
PMID:26318166
RGD:11528126
NCBI chr19:12,353,760...12,355,598
Ensembl chr19:13,097,931...13,098,974
G
KEAP1
kelch like ECH associated protein 1
ISO
DNA:missense mutations, frameshift mutations:cds:multiple (human)
RGD
PMID:18692501
RGD:6893398
NCBI chr19:10,037,544...10,055,091
Ensembl chr19:10,701,303...10,717,604
G
KRAS
KRAS proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:6320174 PMID:11745231 PMID:15696205 PMID:16051643 PMID:17704260 PMID:25741868 PMID:26242988 PMID:28492532 PMID:31666701 PMID:35658005 More...
NCBI chr12:61,062,689...61,108,524
Ensembl chr12:63,679,293...63,724,335
G
LRP1B
LDL receptor related protein 1B
ameliorates
ISO
DNA:mutations:multiple: (human)
RGD
PMID:32898339
RGD:150429787
NCBI chr2B:17,702,178...19,611,567
Ensembl chr2B:144,382,759...146,221,243
G
PIK3CA
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:15520168 PMID:15608678 PMID:15930273 PMID:17673550 PMID:21078999 PMID:22658544 PMID:22729223 PMID:22729224 PMID:23946963 PMID:25599672 PMID:25741868 PMID:25880439 PMID:26627007 PMID:26637981 PMID:27631024 PMID:28151489 PMID:28425981 PMID:29661094 PMID:30376034 PMID:30543347 PMID:31536475 PMID:37712948 More...
NCBI chr 3:176,182,765...176,272,024
Ensembl chr 3:184,355,785...184,441,977
G
RBP4
retinol binding protein 4
disease_progression
ISO
associated with type 2 diabetes mellitus; protein:decreased expression:blood serum (human)
RGD
PMID:37273108
RGD:329849105
NCBI chr10:90,337,879...90,347,530
Ensembl chr10:93,848,166...93,857,887
G
RICTOR
RPTOR independent companion of MTOR complex 2
ISO
DNA:CNV, amplification:exon (human)
RGD
PMID:24508317
RGD:152995522
NCBI chr 5:71,299,215...71,435,290
Ensembl chr 5:76,389,130...76,469,830
G
SMAD4
SMAD family member 4
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:10479724 PMID:10764709 PMID:16152648 PMID:16436638 PMID:21465659 PMID:22810475 PMID:23239472 PMID:25931195 PMID:26467025 PMID:26689913 PMID:28492532 PMID:30851333 PMID:31949278 PMID:32561076 PMID:32719554 PMID:34393517 PMID:35982159 PMID:36158166 PMID:36451132 PMID:37319387 More...
NCBI chr18:44,402,112...44,456,779
Ensembl chr18:47,764,568...47,797,359
G
TP53
tumor protein p53
ISO
ClinVar Annotator: match by term: Gallbladder cancer
ClinVar
PMID:1631137 PMID:1978757 PMID:7478555 PMID:7791795 PMID:8023157 PMID:8062826 PMID:8099841 PMID:8276238 PMID:8425176 PMID:8527048 PMID:8688334 PMID:9150393 PMID:9242456 PMID:9598730 PMID:9825943 PMID:10089074 PMID:11051239 PMID:11370630 PMID:11782540 PMID:11793474 PMID:12406399 PMID:12506399 PMID:12826609 PMID:14673037 PMID:14743206 PMID:15925506 PMID:15993273 PMID:16199547 PMID:16818505 PMID:16861262 PMID:16969106 PMID:17390010 PMID:17417627 PMID:17427234 PMID:17567834 PMID:17572079 PMID:17606709 PMID:17881637 PMID:18978813 PMID:19378321 PMID:19556618 PMID:19711436 PMID:19714490 PMID:20013323 PMID:20128691 PMID:20182602 PMID:20407015 PMID:20436704 PMID:20522432 PMID:21059199 PMID:21305319 PMID:21343334 PMID:21519010 PMID:21601526 PMID:21665182 PMID:21761402 PMID:22186996 PMID:22265402 PMID:22713868 PMID:22915647 PMID:22955915 PMID:23172776 PMID:23246812 PMID:23667202 PMID:23894400 PMID:23950206 PMID:24033266 PMID:24038938 PMID:24382691 PMID:24573247 PMID:24603336 PMID:24651015 PMID:25157968 PMID:25293557 PMID:25544776 PMID:25587027 PMID:25741868 PMID:25925845 PMID:25952993 PMID:26230955 PMID:26425688 PMID:26467025 PMID:26585234 PMID:26619011 PMID:26718964 PMID:26787237 PMID:26911350 PMID:27276561 PMID:27374712 PMID:27463065 PMID:27680515 PMID:27895058 PMID:27959731 PMID:28160093 PMID:28369373 PMID:28472496 PMID:28492532 PMID:28724667 PMID:28861920 PMID:28975465 PMID:29025599 PMID:29324801 PMID:29752822 PMID:29979965 PMID:30224644 PMID:30322717 PMID:30327374 PMID:30720243 PMID:31105275 PMID:31127191 PMID:31742824 PMID:31775759 PMID:32187361 PMID:32817165 PMID:33300245 PMID:33471991 PMID:34240179 PMID:36988593 More...
NCBI chr17:7,699,449...7,717,812
Ensembl chr17:7,684,922...7,706,120
G
XRCC1
X-ray repair cross complementing 1
susceptibility
ISO
DNA:polymorphisms: :p.R194W, p.R399Q (human)
RGD
PMID:19266243
RGD:2317128
NCBI chr19:40,485,052...40,522,188
Ensembl chr19:49,094,014...49,125,520
G
ABO
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
ISO
RGD
PMID:7795450
RGD:2317512
NCBI chr 9:104,354,115...104,399,057
Ensembl chr 9:132,989,574...133,010,324
G
ACTR3
actin related protein 3
severity
ISO
Squamous Cell/Adenosquamous Carcinoma and Adenocarcinoma;protein:increased expression:gall bladder (human)
RGD
PMID:23320827
RGD:11571623
NCBI chr2B:827,184...900,424
Ensembl chr2B:114,373,392...114,445,729
G
ANTXR1
ANTXR cell adhesion molecule 1
severity
ISO
RGD
PMID:21545221
RGD:9684943
NCBI chr2A:69,054,253...69,290,554
Ensembl chr2A:70,175,982...70,412,454
G
BIRC3
baculoviral IAP repeat containing 3
exacerbates
ISO
mRNA:increased expression:gall bladder (human)
RGD
PMID:28295868
RGD:153297817
NCBI chr11:97,269,778...97,290,112
Ensembl chr11:100,763,274...100,785,194
G
CFL1
cofilin 1
severity
ISO
Squamous Cell/Adenosquamous Carcinoma and Adenocarcinoma;protein:increased expression:gall bladder (human)
RGD
PMID:23320827
RGD:11571623
NCBI chr11:61,215,092...61,218,628
Ensembl chr11:64,544,275...64,550,806
G
CLPTM1L
CLPTM1 like
susceptibility
ISO
DNA:SNP, haplotype: :rs401681(human)
RGD
PMID:29450669
RGD:150530629
Ensembl chr 5:1,361,571...1,388,415
G
GPX3
glutathione peroxidase 3
severity
ISO
protein:decreased expression:gallbladder (human)
RGD
PMID:24167362
RGD:151665515
NCBI chr 5:146,447,939...146,456,476
G
IL10
interleukin 10
susceptibility
ISO
associated with Cholelithiasis
RGD
PMID:19065724
RGD:2317654
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
MTUS1
microtubule associated scaffold protein 1
disease_progression
ISO
RGD
PMID:31882471
RGD:25330344
NCBI chr 8:16,863,307...17,020,684
G
PTCH1
patched 1
disease_progression
ISO
RGD
PMID:22407314
RGD:150523794
NCBI chr 9:66,542,675...66,616,820
Ensembl chr 9:94,668,365...94,741,453
G
RAC1
Rac family small GTPase 1
exacerbates
ISO
protein:increased expression:gallbladder (human)
RGD
PMID:21853342
RGD:155230819
NCBI chr 7:7,039,379...7,068,866
G
TERT
telomerase reverse transcriptase
susceptibility
ISO
DNA:SNP, haplotype: :rs2736100(human)
RGD
PMID:29450669
RGD:150530629
Ensembl chr 5:1,300,960...1,338,872
G
TGFA
transforming growth factor alpha
ISO
RGD
PMID:9542514
RGD:2317470
NCBI chr2A:70,510,727...70,617,628
Ensembl chr2A:71,625,196...71,731,461
G
TJP1
tight junction protein 1
ISO
protein:decreased expression:gallbladder
RGD
PMID:19184677
RGD:2325030
NCBI chr15:981,198...1,249,292
Ensembl chr15:26,344,878...26,598,878
G
TYMP
thymidine phosphorylase
disease_progression
ISO
RGD
PMID:18946757
RGD:2325157
NCBI chr22:30,772,088...30,776,618
G
UBR5
ubiquitin protein ligase E3 component n-recognin 5
ameliorates
ISO
human cell line in a mouse model
RGD
PMID:30775814
RGD:151665192
NCBI chr 8:98,904,557...99,064,121
Ensembl chr 8:101,067,435...101,224,913
G
APC
APC regulator of WNT signaling pathway
ISO
ClinVar Annotator: match by term: Intrahepatic cholangiocarcinoma
ClinVar
PMID:24728327 PMID:25479140 PMID:25741868 PMID:26467025 PMID:26530882 PMID:28135048 PMID:28195569 PMID:28492532 PMID:32390703 More...
NCBI chr 5:108,070,697...108,208,273
Ensembl chr 5:113,904,352...114,009,709
G
ARID1A
AT-rich interaction domain 1A
disease_progression exacerbates
ISO
mRNA,protein:decreased expression:intrahepatic bile duct (human)
RGD
PMID:27433094 PMID:30849962 PMID:31665232
RGD:126775257 RGD:126781775 RGD:14974231
NCBI chr 1:25,960,868...26,047,057
Ensembl chr 1:27,018,616...27,103,239
G
BAP1
BRCA1 associated deubiquitinase 1
disease_progression
ISO
RGD
PMID:27864835
RGD:150340628
NCBI chr 3:52,344,067...52,352,187
Ensembl chr 3:53,573,785...53,581,943
G
BECN1
beclin 1
disease_progression
ISO
RGD
PMID:30849962
RGD:14974231
NCBI chr17:14,493,619...14,507,809
Ensembl chr17:14,719,781...14,733,286
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
severity
ISO
DNA:missense mutation:cds:p.V600E (human)
RGD
PMID:24139215
RGD:14398746
NCBI chr 7:132,651,908...132,855,422
Ensembl chr 7:145,138,510...145,327,115
G
FAS
Fas cell surface death receptor
disease_progression
ISO
RGD
PMID:11003620
RGD:14700701
NCBI chr10:85,707,457...85,741,539
Ensembl chr10:89,217,949...89,243,612
G
FASLG
Fas ligand
severity
ISO
RGD
PMID:11003620
RGD:14700701
NCBI chr 1:148,159,826...148,167,785
Ensembl chr 1:151,868,430...151,876,281
G
FOXP3
forkhead box P3
ISO
DNA:hypomethylation:liver
RGD
PMID:24291052
RGD:38599002
NCBI chr X:41,550,462...41,567,492
Ensembl chr X:49,402,652...49,417,029
G
HSP90AA1
heat shock protein 90 alpha family class A member 1
disease_progression
ISO
protein:increased expression:liver (human)
RGD
PMID:24796583
RGD:152177907
NCBI chr14:82,700,881...82,707,020
Ensembl chr14:102,519,699...102,576,723
G
HSP90AB1
heat shock protein 90 alpha family class B member 1
disease_progression
ISO
protein:increased expression:liver (human)
RGD
PMID:24796583
RGD:152177907
NCBI chr 6:43,842,796...43,849,637
Ensembl chr 6:45,125,773...45,133,872
G
IDH1
isocitrate dehydrogenase (NADP(+)) 1
no_association
ISO
DNA:misssense mutations:cds:p.Arg132Cys,Arg132Leu (human)
RGD
PMID:26245674
RGD:14974229
NCBI chr2B:95,475,320...95,494,286
Ensembl chr2B:213,599,036...213,617,175
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
disease_progression
ISO
DNA:mutations: : mRNA:decreased expression:liver (mouse)
RGD
PMID:22824796 PMID:32463951
RGD:149735894 RGD:14985256
NCBI chr15:68,771,050...68,790,523
Ensembl chr15:87,972,889...87,991,276
G
KDM5C
lysine demethylase 5C
exacerbates
ISO
protein:decreased expression:bile duct (human)
RGD
PMID:32714863
RGD:151361175
NCBI chr X:45,377,609...45,440,025
Ensembl chr X:53,515,886...53,548,785
G
KRAS
KRAS proto-oncogene, GTPase
disease_progression
ISO
DNA:mutations::
RGD MouseDO
PMID:24139215
RGD:14398746
NCBI chr12:61,062,689...61,108,524
Ensembl chr12:63,679,293...63,724,335
G
LCN2
lipocalin 2
treatment
ISO
Protein:increased expression:bile duct
RGD
PMID:24939880
RGD:126790491
NCBI chr 9:99,259,278...99,274,494
Ensembl chr 9:127,940,799...127,944,798
G
LRP1B
LDL receptor related protein 1B
exacerbates
ISO
DNA:mutations:multiple: (human)
RGD
PMID:33014052
RGD:150429786
NCBI chr2B:17,702,178...19,611,567
Ensembl chr2B:144,382,759...146,221,243
G
MAGI1
membrane associated guanylate kinase, WW and PDZ domain containing 1
disease_progression
ISO
protein:increased expression:intrahepatic bile duct (human)
RGD
PMID:30377796
RGD:152998946
NCBI chr 3:65,257,763...65,932,527
Ensembl chr 3:66,635,580...66,757,358
G
PBRM1
polybromo 1
disease_progression
ISO
protein:increased expression:intrahepatic bile duct (human)
RGD
PMID:27864835 PMID:30377796
RGD:150340628 RGD:152998946
NCBI chr 3:52,487,083...52,626,418
Ensembl chr 3:53,718,051...53,850,146
G
PTEN
phosphatase and tensin homolog
disease_progression
ISO
protein:decreased expression:liver (human)
RGD
PMID:24796583
RGD:152177907
NCBI chr10:84,587,841...84,689,043
Ensembl chr10:88,093,539...88,194,605
G
RNF43
ring finger protein 43
exacerbates
ISO
mRNA, protein:decreased expression:liver, bile duct epithelium (human)
RGD
PMID:26980022
RGD:151361125
NCBI chr17:52,420,516...52,492,813
Ensembl chr17:57,276,761...57,347,748
G
S100B
S100 calcium binding protein B
disease_progression
ISO
protein:increased expression:intrahepatic bile duct (human)
RGD
PMID:30377796
RGD:152998946
NCBI chr21:33,063,845...33,070,073
Ensembl chr21:46,197,750...46,203,953
G
SMAD4
SMAD family member 4
disease_progression
ISO
mRNA,protein:decreased expression:intrahepatic bile duct
RGD
PMID:16917866 PMID:23981608
RGD:18936999 RGD:21066336
NCBI chr18:44,402,112...44,456,779
Ensembl chr18:47,764,568...47,797,359
G
TEP1
telomerase associated protein 1
ISO
mRNA:increased expression:hepatocyte,biliary epithelium.
RGD
PMID:10498642
RGD:152977753
NCBI chr14:1,240,370...1,285,787
Ensembl chr14:19,293,452...19,332,960
G
APC
APC regulator of WNT signaling pathway
ISO
ClinVar Annotator: match by term: Klatskin tumor
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 5:108,070,697...108,208,273
Ensembl chr 5:113,904,352...114,009,709
G
ARID1A
AT-rich interaction domain 1A
disease_progression
ISO
DNA:deletions
RGD
PMID:33387086
RGD:126848756
NCBI chr 1:25,960,868...26,047,057
Ensembl chr 1:27,018,616...27,103,239
G
GATA6
GATA binding protein 6
sexual_dimorphism
ISO
DNA:mutations
RGD
PMID:33387086
RGD:126848756
NCBI chr18:15,411,764...15,444,402
G
KMT2C
lysine methyltransferase 2C
onset
ISO
DNA:mutations
RGD
PMID:33387086
RGD:126848756
NCBI chr 7:143,714,716...144,016,188
Ensembl chr 7:155,862,610...156,081,043
G
KRAS
KRAS proto-oncogene, GTPase
disease_progression
ISO
DNA:mutations
RGD
PMID:33387086
RGD:126848756
NCBI chr12:61,062,689...61,108,524
Ensembl chr12:63,679,293...63,724,335
G
PREX2
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2
sexual_dimorphism
ISO
DNA:substitutions, insertion/deletions: (human)
RGD
PMID:33387086
RGD:126848756
NCBI chr 8:64,489,817...64,769,602
Ensembl chr 8:66,215,974...66,430,138
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all